Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medical Device Giants Fight For Basic-Level Market

This article was originally published in PharmAsia News

Executive Summary

At the recent 60th China International Medical Equipment Fair in Suzhou, medical device giants gave emphasis to products suitable for small and medium health care institutions. GE Healthcare used the event to debut its new products specially developed for rural and community health care services. Its R&D center in China will add 20 new recruits to the existing 100 researchers to develop products for the grass root market. Meanwhile, Siemens highlighted its product line,which is being deployed in the rural market. Hitherto the main market of local medical device manufacturers, basic-level business is seeing increasing competitive pressure from MNCs. Technology represents the weak link for the Chinese companies as innovation needs to be a continuous process. (Click here for more - Chinese Language)

You may also be interested in...



Google Teams Up With Mayo Clinic To Explore AI To Improve Radiotherapy Planning

Mayo Clinic announces AI-based partnerships with Google and voice-analysis company Vocalis Health this week.

FDA’s Final MOU On Interstate Compounding Now Awaits Signatures From States

US pharmacy group says that 10 to 12 states have indicated through an informal survey that they do not have the manpower or funding to implement the US FDA’s final MOU on inordinate compounding. They say what is at stake in these states is patient access to compounded medicines.

Medtronic Expands ENT Portfolio With Ai Biomed Acquisition, NIM Vital Clearance

Ai Biomed’s PTeye helps to identify parathyroid tissue during thyroid surgery. Medtronic ENT also announced the FDA clearance of its NIM Vital electromyographic system for nerve monitoring during surgery.

UsernamePublicRestriction

Register

LL1134468

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel